-

Global Asthma Clinical Trial Pipeline Highlights 2020 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Asthma Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering.

This report provides the most up-to-date information on key pipeline products in the global asthma market. It covers emerging therapies for Asthma in active clinical development stages including early and late-stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Asthma pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Asthma pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Asthma pipeline products by company.

Short-term Launch Highlights:

Find out which Asthma pipeline products will be launched in the US and beyond to 2025.

Key Topics Covered:

1. Asthma Pipeline by Stages

2. Asthma Phase 3 Clinical Trial Insights

3. Asthma Phase 2 Clinical Trial Insights

4. Asthma Phase 1 Clinical Trial Insights

5. Asthma Preclinical Research Insights

6. Asthma Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables

Table 1: Asthma Phase 3 Clinical Trials, 2020

Table 2: Asthma Phase 2 Clinical Trials, 2020

Table 3: Asthma Phase 1 Clinical Trials, 2020

Table 4: Asthma Preclinical Research, 2020

Table 5: Asthma Discovery Stage, 2020

List of Figures

Figure 1: Asthma Pipeline Molecules by Clinical Trials Stage, 2020

Figure 2: Asthma Phase 3 Clinical Trial Highlights, 2020

Figure 3: Asthma Phase 2 Clinical Trial Highlights, 2020

Figure 4: Asthma Phase 1 Clinical Trial Highlights, 2020

Figure 5: Asthma Preclinical Research Highlights, 2020

Figure 6: Asthma Discovery Stage Highlights, 2020

For more information about this report visit https://www.researchandmarkets.com/r/iqbvwm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom